Your session is about to expire
← Back to Search
Work-Focused Program for Substance Use Disorders
N/A
Recruiting
Led By Joanna M. Fiszdon, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be 18 years of age and older
Must be competent to give written informed consent and HIPAA authorization
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether work-focused programs can help Veterans in early recovery from substance use disorder achieve sobriety and other better clinical outcomes.
Who is the study for?
This trial is for Veterans diagnosed with any Substance Use Disorder (SUD) such as opioids or alcohol, who are enrolled in VACHS substance use treatment and are within 30 days of detoxification. Participants must be over 18, able to consent, and not planning to relocate or likely to be incarcerated during the study.
What is being tested?
The trial is testing if work-focused programs can help improve sobriety and overall functioning in Veterans recovering from SUDs. It randomly assigns participants to either receive a referral for these programs or continue with their usual treatment without additional work focus.
What are the potential side effects?
Since this trial involves referral to therapeutic work activities rather than medication, traditional side effects like those seen with drugs aren't expected. However, there may be stress or emotional impacts associated with participating in work-focused therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am able to understand and sign the consent form.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical Global Impression
percent days abstinent
Secondary study objectives
change from baseline in BASIS-24
change from baseline in New General Self-Efficacy Scale
change from baseline in Rosenberg self-esteem scale
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: treatment as usual plus referral to work focused programExperimental Treatment2 Interventions
usual substance use treatment plus referral to a competitive or non-competitive work-focused program
Group II: treatment as usualActive Control1 Intervention
usual substance use treatment
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,726 Total Patients Enrolled
Joanna M. Fiszdon, PhDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT
2 Previous Clinical Trials
220 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am able to understand and sign the consent form.
Research Study Groups:
This trial has the following groups:- Group 1: treatment as usual
- Group 2: treatment as usual plus referral to work focused program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.